Signaturefd, LLC Hutchmed (China) LTD Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$15.52 - $35.65 $11,748 - $26,987	-757 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$28.89 - $35.33 $8,204 - $10,033	284 Added 60.04%	757 $27,000
Q3 2021 Oct 28, 2021	BUY	$35.66 - $42.94 $3,280 - $3,950	92 Added 24.15%	473 $17,000
Q2 2021 Jul 26, 2021	BUY	$23.7 - $39.27 $2,535 - $4,201	107 Added 39.05%	381 $15,000
Q1 2021 Apr 30, 2021	BUY	$27.01 - $36.8 $1,080 - $1,472	40 Added 17.09%	274 $8,000
Q4 2020 Feb 11, 2021	BUY	$27.51 - $34.36 $2,283 - $2,851	83 Added 54.97%	234 $7,000
Q3 2020 Nov 03, 2020	BUY	$25.8 - $34.61 $774 - $1,038	30 Added 24.79%	151 $5,000
Q2 2020 Jul 30, 2020	BUY	$17.65 - $28.05 $2,135 - $3,394	121 New	121 $3,000

6.77M

8.2K

9.2K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.75B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.